Pagina 6 - I migliori diagnostici di Diagnostica - TOP-240 medici

Dr. Isik Okuyan is an obstetrics and gynecology specialist at Memorial Göztepe Hospital in Istanbul (2025–present). He previously worked at Şanlıurfa Training and Research Hospital (2023–2025). He completed his OB/GYN residency at SB University Istanbul Training and Research Hospital (2019–2023). He earned his MD from Mersin University (2011–2017).

His credentials include GESEA Level 1 in Gynecological Endoscopy (Marseille, 2024). He presented a video and a poster at the 33rd ESGE Congress (2024). He is a member of the Turkish Medical Association, the Turkish Society of Gynecology and Obstetrics, and ESGE. He took part in meetings from 2022 to 2025, including ISON and national gynecology congresses.

Dr. Ahmet Ekmekci is a cardiology specialist at Memorial Göztepe Hospital in Istanbul, since 2025. He earned the title of Associate Professor of Cardiology (Doçent) in 2014.

He served as Chief Assistant in Cardiology at Dr. Siyami Ersek Training and Research Hospital in 2010. He completed his cardiology residency at the same hospital in 2009. He finished his internal medicine residency at the Istanbul Faculty of Medicine from 2002 to 2007. He received his MD from Istanbul University, Istanbul Faculty of Medicine, in 2002.

He is a member of the Turkish Society of Cardiology, the European Society of Cardiology, and the European Heart Failure Association (Gold Member). He is also a member of the Istanbul Internal Medicine Association, the Stem Cell and Cellular Therapies Association, the Istanbul Medical Chamber, and the Turkish Medical Association. He served on the Board of the Turkish Society of Cardiology Heart Failure Working Group in 2016.

Dr. Aygul Aliyeva Onen is a specialist in obstetrics and gynecology at Memorial Göztepe Hospital (2025–present). She previously worked at Medical Park Göztepe (2023–2025) and at Celal Bayar University Hafsa Sultan Hospital (2018–2023). She completed her obstetrics and gynecology residency at Celal Bayar University Faculty of Medicine (2018–2023). She graduated from Azerbaijan Medical University (2010–2016) and completed an observership at Ege University (2017).

Professional memberships include the Istanbul Medical Chamber, the Turkish Society of Gynecology and Obstetrics, and the Pelvic Floor and Cosmetic Gynecology Association. Additional training includes Current Approaches in Cosmetic Gynecology (TJOD Izmir); CCI HADYEK Laparoscopic Gynecologic Surgery; Sexual Health Federation—Vaginismus and Dyspareunia; the 1st–3rd International Pelvic Floor and Cosmetic Gynecology Congresses; and the TJOD Obstetric Simulation Course.

Dr. Basak Sargin is an obstetrics and gynecology (OB/GYN) specialist at Memorial Göztepe Hospital. She has worked at Medipol Mega University Hospital (IVF and Reproductive Health Center), Medipol Acıbadem Region, Memorial Ataşehir Hospital, and Kars Harakani State Hospital.

Accreditations: FMAS and DMAS, World Laparoscopy Hospital (2023). ART training, American Hospital (07/2024–01/2025). Fellowships: Minimally Invasive and Advanced Gynecologic Surgery, Pius University, Oldenburg (07/2025); World Laparoscopy Hospital (05/2023). Additional training in robotic surgery, hysteroscopy, vNOTES, embryo transfer simulation, and laser/magnetic stimulation.

Education: MD, Hacettepe University. OB/GYN residency, Ankara (2016–2021). PhD candidate in Biomedical Engineering, Koç University (since 2023). Memberships: SRGS, International Society of Gynecology and Obstetrics, ESGE, WALS, and Istanbul Medical Chamber.

Professor of Thoracic Surgery (2013–present). Thoracic Surgery Specialist at Memorial Göztepe (2025–present) and Memorial Ataşehir (2024–present), Istanbul. Former Chair, Department of Thoracic Surgery, Marmara University School of Medicine (2018–2024).

MD, Marmara University (1993). Completed thoracic surgery residency in 2000. International training at Marie Lannelongue Hospital, Paris (2000–2008). Further training at Toronto General Hospital, Thoracic Surgery & Lung Transplantation Clinic (2013), and UC San Diego, Pulmonary Endarterectomy & Lung Transplant Clinic (2013).

Publications in the European Journal of Cardio-Thoracic Surgery, Annals of Thoracic Surgery, and Thoracic and Cardiovascular Surgeon. Topics include pulmonary endarterectomy (PEA) for chronic thromboembolic pulmonary hypertension (CTEPH) (2013) and massive hemorrhage after PEA (2012). They also cover PEA in Behçet’s disease (2018), sleeve lobectomy (2007), and surgery for T4 non–small cell lung cancer over 25 years (2008).

Dr. Berrak Beyoglu Oruc is a specialist in obstetrics, gynecology, and IVF at Memorial Göztepe Hospital (2025–). She previously worked at Bahçeşehir University Medical Park Göztepe Hospital and Ağrı Training and Research Hospital. She also served as a research physician in gynecologic oncology at Bologna University S. Orsola (2022).

Accreditations and key training include: Certified ART Clinical Training, American Hospital (2025); GESEA MIGS Level 1 – European Certified Minimal Invasive Gynaecological Surgeon (2024). She also completed the Harvard Women’s Health and Menopause Course (2025), ESGO ORSI Robotic Surgery (2022), ESGO Masterclass (2022), and TMFTP Second Trimester Ultrasound (2024).

Awards: First prize, oral presentation—Transperineal Ultrasonography in Predicting Operative Delivery (13th Maternal–Fetal Medicine and Perinatology Congress, 2023). Third prize—Aortic Dissections (2016). Memberships: ISUOG, ESGE, MIJID, TJOD.

Dr. Haluk Caglar Karakaya is a specialist in cardiovascular surgery at Memorial Göztepe Hospital in Istanbul (2025–). He previously worked as a specialist at the University of Health Sciences Sancaktepe Şehit Prof. Dr. İlhan Varank Training and Research Hospital (2022–2025). He completed residency training at the University of Health Sciences Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital and at Ankara University. He earned his MD from Hacettepe University (English program).

Professional memberships: European Society for Cardiothoracic Surgery (EACTS), European Society for Vascular Surgery (ESVS), Turkish Society of Cardiovascular Surgery, National Society of Vascular and Endovascular Surgery.

Continuing education: 27th European Vascular Course (2024); Cardiac Memorial Robotic/Minimally Invasive Cardiac Surgery Summit (2024); 18th Turkish Cardiovascular Surgery Congress (2024); 24th ASVS Congress (2023); TKDCD Endovascular Course (2023); “Grey Areas in Vascular Surgery” Symposium (2023); Basic and Advanced Doppler Ultrasonography Course (2023).

Dr. Derya Can has been an Assistant Professor of Dermatology at Medipol Health Group since 2021. She diagnoses and treats diseases of the skin, hair, nails, and mucosa. Her areas of expertise include eczema, atopic dermatitis, acne, psoriasis, sexually transmitted infections, warts, herpes, shingles, and fungal infections.

Dr. Can manages both benign and malignant skin tumors. She also treats hair and nail disorders, vitiligo, and other common skin conditions. She performs advanced procedures such as hair transplantation and PRP therapy for hair loss.

Assoc. Prof. Dr. Murat Damar is an ENT specialist at Private Optimed International Çorlu Hospital, ENT Clinic. He graduated from Uludağ University in 1997. He completed ENT residency training at Istanbul University from 2004 to 2009.

He has authored 18 international and 2 national peer-reviewed articles. He has also presented 9 international and 16 national congress papers. His research focuses on chronic otitis media, septal deviation, salivary gland tumors, sleep apnea biomarkers, and myringoplasty materials. He completed advanced courses in live head and neck tumor surgery, applied thyroid ultrasound, and several endoscopic sinus surgery cadaver masterclasses. He speaks English.

Education:

• Degree: Faculty of Medicine, Trakya University, 2009
• Medical Specialty: Internal Medicine, Bakırköy Dr. Sadi Konuk Training and Research Hospital, 2010-2014
• Specialist Doctor: Internal Medicine, Kanuni Sultan Süleyman Training and Research Hospital, 2014-2019
• Specialist Doctor: Internal Medicine, Turkish Hospital Internal Medicine Clinic, Qatar, 2019-2020
• Specialist Doctor: Internal Medicine, Istanbul Medipol University Hospital Mega Hospital Internal Medicine Department, 2020-2024
• Associate Professor Doctor: Internal Medicine, Istanbul Medipol University Medipol Acıbadem Regional Hospital, 2024-Present.

Roles in Projects:

Sub investigator (Assistant Researcher) in the SOUL Study: Cardiovascular Outcome Research of Semaglutide in Type 2 Diabetic Patients, approved by the Turkish Medicines and Medical Devices Agency on May 22, 2019.

Sub investigator (Assistant Researcher) in the international study “SCALE™ Insulin”: Efficacy and Safety of Liraglutide 3.0 mg in Overweight or Obese Patients with Type 2 Diabetes Treated with Basal Insulin (Study Code: NN8022-4272), conducted by Novo Nordisk A.Ş.

Subinvestigator (Assistant Researcher) in the international study NN5401-4266 StepByStep Intensification conducted by Novo Nordisk.

Assistant Researcher in the study "A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes (SUSTAIN 11)" (2019-2020).

Assistant Researcher in the PIONEER 1 study: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes.

EDUCATION:

2015

Uludag University, Ophthalmology

2008

Eskisehir Osmangazi University, Faculty of Medicine

2001

Kırıkkale Science High School, Numerical

EXPERIENCE:

2019 Gazi University Faculty of Medicine Ophthalmology (Vitreo-Retinal Surgery and Medical Retina Fellowship)

2016 SBÜ Zekai Tahir Burak EAH (Retinopathy of Prematurity Fellowship)/

2015 - 2023 Kocaeli Derince Training and Research Hospital

2023 - Medipol University Pendik Hospital

Diseases

• Lung Cancer
• Skin Cancers
• Gastrointestinal Cancers
• Genitourinary Cancers
• Gynecological Cancers
• Colon Cancer
• Breast Cancer
• Rare Cancers

Treatment Methods

• Individual Treatments (Comprehensive Genomic Profiling)
• Targeted Therapies
• Immunotherapy
• Cancer Vaccines
• Chemotherapy
• Clinical Research/Experimental Medical Research

Experience

• 2017- 2024: Katip Çelebi University Faculty of Medicine Atatürk Education and Research Hospital Medical Oncology Clinic Associate Professor / Lecturer
• 2022 December – 2023 March: Academic visitor Moffitt Cancer Center Cutaenous Oncology Clinic Tampa, Florida USA
• 2013- 2017: Katip Çelebi University Faculty of Medicine Atatürk Training and Research Hospital – Medical Oncology Clinic Specialist Physician
• 2012-2013: Izmir Education and Research Hospital, Medical Oncology Specialist Physician
• 2012-2012: Mersin State Hospital, Medical Oncology Specialist Physician
• 2010-2012: Dokuz Eylül University Faculty of Medicine, Department of Medical Oncology, Sub-branch Research Assistant
• June-August 2008, December 2008 – February 2009: Memorial Sloan Kettering Cancer Center Observership programme
• 2007-2009: Kartal Education and Research Hospital, Medical Oncology Sub-branch Research Assistant
• 2006-2007: Siirt State Hospital, Internal Medicine, Specialist Physician
• 2005-2006: Çukurova University Faculty of Medicine, Medical Oncology Sub-branch Research Assistant
• 2004-2005: SSK Siirt Hospital, Internal Medicine Specialist Physician
• 2003-2004: SSK Mardin Hospital, Internal Medicine Specialist Physician
• 1998-2003: SSK Izmir Training and Research Hospital, 3rd Internal Medicine Clinic, Research Assistant
• 1998-1998: SSK Izmir Training and Research Hospital Infectious Diseases Research Assistant
• 1997-1998: Izmir Ataturk Training and Research Hospital, Anesthesiology and Reanimation Clinic, Research Assistant
• 1995-1997: Şırnak Cizre Central Health Center
• 1994-1995: Şırnak İdil Oyalı Village Health Center

Professional Memberships

• Turkish Society of Medical Oncology 2008 
• (2018-2021 Term Board Member)
• Izmir Oncology Group, Board Member (2014 -…)
• Geriatric Oncology Association, Board Member (2015-…)
• Mediterranean Oncology Association Board Member (2020 -…)
• Turkish Biochemistry Association, Member, 2016
• European Society of Medical Oncology, Member, 2012
• American Society of Clinical Oncology, Member, 2008

EDUCATION:

2000 - SSK Okmeydanı Training and Research Hospital, .

1996 - Istanbul University, Istanbul Faculty of Medicine

EXPERIENCE:

2019 - Istanbul Medipol University Pendik Hospital

2017 - 2019 - Private Adatıp Kurtköy Hospital

2005 - 2017 - Private Avicenna Umut Hospital

2003 - 2005 - SSK Yalova Regional Hospital

2002 - 2003 - Kayseri Military Hospital

EDUCATION:

2009

Ankara Etlik Maternity Hospital and Gynecology Education and Research Hospital, Gynecology and Obstetrics

2003

Ankara University, Faculty of Medicine

EXPERIENCE:

2019 - to present

Medipol University Pendik Hospital

2009 - 2019

Yakacık Maternity and Child Diseases Hospital

PUBLICATIONS:

Articles Published in Journals Indexed in SCI, SSCI and AHCI

Isoflavones obtained from red clover improve both dyslipidemia and menopausal symptoms in menopausal women: a prospective randomized placebo-controlled trial

YİĞİT E., ÜNSAL S.

Climacteric , 2024 (SCI-Expanded)

Dr. Cemal Aydin specializes in interventional radiology. He earned his medical degree from the Marmara University Faculty of Medicine (2007–2013). In 2014, he worked as a general practitioner at the Kars Provincial Health Directorate. He then completed his residency in interventional radiology at Marmara University Hospital (2014–2020). He served as Head Physician, Radiology, at Yüksekova State Hospital (2020–2021). From 2021 to 2023, he practiced interventional radiology at Koç University Hospital.

He presented at the 37th and 38th National Radiology Congress. In 2016, he reported on lobar distribution of liver metastases in primary pancreatic adenocarcinoma. In 2017, he compared procedure times and complication rates for Trucut biopsy versus FNAB in lung biopsies with risk factors. He also studied diffusion‑weighted MRI to distinguish CPA meningioma and vestibular schwannoma.

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Dr. Zuhal Cakmak Peksen is a Family Medicine Specialist since 2017. She earned her MD from Çukurova University in 2010. She completed specialty training at Yüzüncü Yıl University between 2013 and 2017. She is currently studying for a bachelor’s degree in Health Management at Anadolu University (2024–present).

She has 15 years of clinical practice (2010–2025) across 8 institutions. Her experience includes research in Family Medicine (2013–2017) and work at several Family Health Centers. Since 2020, she has served at TOKİ Avrupa Family Health Center in Gaziosmanpaşa, Istanbul.

Dr. Mustafa Serkan Durdu is a cardiovascular surgeon at Memorial Ankara Hospital (2022–present). He previously worked at the Ankara University Department of Cardiovascular Surgery. His focus is minimally invasive valve surgery. He performs right anterior minithoracotomy, sutureless aortic valve replacement, multiple valve implantation, and combined valve surgery with right coronary artery bypass.

He has peer-reviewed publications in J Thorac Cardiovasc Surg, Thorac Cardiovasc Surg, Heart Lung Circ, Semin Thorac Cardiovasc Surg, and Cardiovasc Ther. His work includes studies on molecular signatures of chronic atrial fibrillation in primary mitral regurgitation. Qualifications: Cardiovascular Surgery specialization (Ankara University) and MD (Erciyes University). Memberships: EACTS, ISMICS, MIRC, Turkish Society of Cardiovascular Surgery, National Society of Vascular Surgery, and Turkish Society of Hematology.

Dr. Hülya Gürel Savaş is a Radiology Specialist at Memorial Bodrum Hospital (2025–present). She has 13 years of specialist experience. Her previous posts include Samsun Büyük Anadolu Hospital (2020–2025), Gaziantep Şehitkamil State Hospital (2017–2020), Samsun Training and Research Hospital (2015–2016), Bafra State Hospital (2014–2015), and Nizip State Hospital (2012–2014).

She completed her radiology residency at Ondokuz Mayıs University (2006–2012). She earned her medical degree there (1995–2001). She is a member of the Turkish Society of Radiology. She completed TSR courses in Breast Imaging and Obstetric Imaging.